Rebekah Harper

Stock Analyst

(n/a)

# 4,425

Out of 4,433 analysts

4

Total ratings

n/a

Success rate

n/a

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General

2 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVS Novartis AG	Upgrades: Neutral	n/a	$102.57	-	3	May 25, 2018
	AZN AstraZeneca	Upgrades: Neutral	n/a	$76.90	-	1	May 15, 2017

Novartis AG

May 25, 2018

Upgrades: Neutral

Price Target: n/a

Current: $102.57

Upside: -

AstraZeneca

May 15, 2017

Upgrades: Neutral

Price Target: n/a

Current: $76.90

Upside: -